Ind-Swift Laboratories shines on acquiring land to set up new R&D Centre in Punjab
Ind-Swift Laboratories is currently trading at Rs. 121.69, up by 5.43 points or 4.67% from its previous closing of Rs. 116.26 on the BSE.
The scrip opened at Rs. 121.99 and has touched a high and low of Rs. 122.07 and Rs. 118.00 respectively. So far 69958 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 186.00 on 02-Aug-2024 and a 52 week low of Rs. 87.00 on 03-Dec-2024.
Last one week high and low of the scrip stood at Rs. 122.07 and Rs. 92.60 respectively. The current market cap of the company is Rs. 721.27 crore.
The promoters holding in the company stood at 42.00%, while Institutions and Non-Institutions held 1.59% and 56.41% respectively.
Ind-Swift Laboratories has completed the acquisition of land at Dera Bassi, Punjab for a total consideration of Rs 1.93 crore for setting up of a new state-of-the-art Research and Development (R&D) Centre.
Earlier, the company had set up a new state-of-the-art marketing office at The Great Eastern Centre, Nehru Place, New Delhi.
Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).
